Development and implementation of PROgmatic: A clinical trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes

被引:26
作者
Cramon, Per [1 ]
Rasmussen, Ase Krogh [1 ]
Bonnema, Steen Joop [2 ]
Bjorner, Jakob Bue [3 ,4 ]
Feldt-Rasmussen, Ulla [1 ]
Groenvold, Mogens [4 ]
Hegedus, Laszlo [2 ]
Watt, Torquil [1 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark
[2] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark
[3] Natl Res Ctr Working Environm, Copenhagen, Denmark
[4] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark
关键词
GRAVES HYPERTHYROIDISM; QUESTIONNAIRE; VACCINATION; VALIDITY;
D O I
10.1177/1740774513517778
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Many clinical trials are conducted as explanatory trials, but the applicability of results from explanatory trials to clinical practice may be questioned. Pragmatic trials elucidate both benefits and harms of an intervention under conditions close to daily clinical practice. We have planned a pragmatic multi-centre trial in patients with Graves' hyperthyroidism. However, trial management is a complicated task in pragmatic trials, due to limited interaction between participants and trial personnel. Purpose The aim of this project was to develop and implement PROgmatic, a fully integrated trial management system for pragmatic multi-centre trials, optimised for electronic data capture and patient-reported outcomes (PROs). Methods Necessary tasks and logistical challenges that should be handled by PROgmatic were identified, and the system was designed and developed to handle these tasks. A combination of generic applications and custom coding was applied to develop an integrated system that met the required needs. PROgmatic features include secure web-based data entry; electronic case report forms (eCRFs); central participant registration and randomisation; automated emails linking to electronic PROs; automated reminders to participants; automated notifications to trial personnel regarding booking of trial visits, safety and compliance alerts; and monitoring of trial progress. PROgmatic underwent rigorous pilot testing, including data verification and validation, before it was released for trial management. Results PROgmatic was successfully implemented in the GRAves' Selenium Supplementation (GRASS) trial (ClinicalTrials.gov: NCT01611896) December 2012. The feedback from trial personnel on usability and utility has been positive, and PROgmatic has handled all intended tasks properly. Limitations Implementation of PROgmatic in future studies requires adaptation of the custom coding. Not all email systems accept emails with active links, and participants who use these systems therefore need to complete paper surveys. Conclusions PROgmatic facilitated the complex task of conducting a pragmatic multi-centre trial. The automated electronic capture of PRO data is time saving and reduces the risk of erroneous data entry. Email notifications to trial personnel combined with serially activated eCRFs that logically lead patient flow through the trial have helped making the pragmatic trial feasible. PROgmatic provides a template for other pragmatic multi-centre trials with patient-reported measures as high-priority outcomes.
引用
收藏
页码:344 / 354
页数:11
相关论文
共 18 条
[11]  
Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217
[12]   Making trials matter: pragmatic and explanatory trials and the problem of applicability [J].
Treweek, Shaun ;
Zwarenstein, Merrick .
TRIALS, 2009, 10
[13]   Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009-2010 season: web-based and telephone evaluation [J].
Wade, Alan G. ;
Crawford, Gordon M. ;
Pumford, Neil ;
McConnachie, Alex .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 :409-420
[14]   STATISTICS IN MEDICINE Pragmatic Trials - Guides to Better Patient Care? [J].
Ware, James H. ;
Hamel, Mary Beth .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18) :1685-1687
[15]   Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing [J].
Watt, Torquil ;
Rasmussen, Ase Krogh ;
Groenvold, Mogens ;
Bjorner, Jakob Bue ;
Watt, Sara Hope ;
Bonnema, Steen Joop ;
Hegedus, Laszlo ;
Feldt-Rasmussen, Ulla .
QUALITY OF LIFE RESEARCH, 2008, 17 (07) :1009-1017
[16]   Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial [J].
Watt, Torquil ;
Cramon, Per ;
Bjorner, Jakob Bue ;
Bonnema, Steen Joop ;
Feldt-Rasmussen, Ulla ;
Gluud, Christian ;
Gram, Jeppe ;
Hansen, Jane Lindschou ;
Hegedus, Laszlo ;
Knudsen, Nils ;
Bach-Mortensen, Pernille ;
Nolsoe, Runa ;
Nygaard, Birte ;
Pociot, Flemming ;
Skoog, Maria ;
Winkel, Per ;
Rasmussen, Ase Krogh .
TRIALS, 2013, 14
[17]   Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO [J].
Watt, Torquil ;
Hegedus, Laszlo ;
Groenvold, Mogens ;
Bjorner, Jakob Bue ;
Rasmussen, Ase Krogh ;
Bonnema, Steen Joop ;
Feldt-Rasmussen, Ulla .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (01) :161-167
[18]   Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination [J].
Watt, Torquil ;
Bjorner, Jakob Bue ;
Groenvold, Mogens ;
Rasmussen, Ase Krogh ;
Bonnema, Steen Joop ;
Hegedus, Laszlo ;
Feldt-Rasmussen, Ulla .
QUALITY OF LIFE RESEARCH, 2009, 18 (04) :483-496